Our analysis suggests that elevated expression levels of INTS1, INTS4, and INTS8 could potentially serve as biomarkers for predicting the survival of HCC patients and are strongly correlated with prognosis. This evidence concerns the gene INTS4 and hepatocellular carcinoma.